Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.06 USD | +0.28% | +25.49% | -20.54% |
12:25pm | North American Morning Briefing : The "Everything -2- | DJ |
05-16 | Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.54% | 814M | |
+9.11% | 114B | |
+11.46% | 104B | |
-13.88% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.73% | 17.89B | |
+7.85% | 14.28B | |
+34.82% | 12.55B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Morgan Stanley Cuts Price Target on Prime Medicine to $12 From $18, Keeps Equalweight Rating